Literature DB >> 22608535

Pheidippides redux: reducing risk for acute cardiac events during marathon running.

Arthur J Siegel1.   

Abstract

Prolonged strenuous exercise such as marathon running transiently increases the absolute and relative risk for sudden cardiac death. A 17-fold increase in the latter over resting baseline in previously sedentary middle-aged men is reduced due to cardioprotection from training in experienced marathon runners. Exertional rhabdomyolysis as a common occurrence during the race is accompanied by neutrophilia and elevated biomarkers of inflammation, including interleukin-6 and C-reactive protein. A hemostatic imbalance with prothrombotic effects includes in vivo platelet activation during the race. Suggesting a pathogenic role for these findings, plaque rupture due to atherothrombosis triggers acute exertional cardiac events, including sudden death, in low-risk runners as in high-risk patients such as those with diabetes mellitus. Strategies including prophylactic aspirin are considered to decrease the risk for acute cardiac events.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22608535     DOI: 10.1016/j.amjmed.2011.11.008

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  5 in total

1.  Evading the fate of Pheidippides: acute coronary thrombosis in a young marathon runner with minimal atherosclerosis but sickle cell trait.

Authors:  Scott W Murray; Robert M Cooper; Joseph D Mills; Nicholas D Palmer
Journal:  Cardiovasc Diagn Ther       Date:  2015-08

Review 2.  The toll of the gridiron: damage-associated molecular patterns and hypertension in American football.

Authors:  Cameron G McCarthy; R Clinton Webb
Journal:  FASEB J       Date:  2015-08-27       Impact factor: 5.191

Review 3.  Prerace aspirin to protect susceptible runners from cardiac arrest during marathons: is opportunity knocking?

Authors:  Arthur J Siegel
Journal:  Open Heart       Date:  2015-07-02

4.  Aspirin Use for Primary Cardiovascular Prevention During the COVID-19 Pandemic.

Authors:  Arthur J Siegel
Journal:  Am J Med       Date:  2021-04       Impact factor: 4.965

5.  Can pre-race aspirin prevent sudden cardiac death during marathons?

Authors:  Arthur J Siegel; Timothy D Noakes
Journal:  Br J Sports Med       Date:  2017-07-19       Impact factor: 13.800

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.